BioNTech eyes COVID vaccine for 12-15 year olds from June in EU
BioNTech said Thursday that it expected its COVID-19 vaccine, jointly developed with Pfizer, to be available to 12-to-15-year-olds in Europe from June.
by ·
BioNTech said Thursday that it expected its COVID-19 vaccine, jointly developed with Pfizer, to be available to 12-to-15-year-olds in Europe from June.
by Linda Brown · Published June 22, 2023 · Last modified December 2, 2024
by · Published June 7, 2021
by · Published April 12, 2021